Technical Analysis for SPRB - Spruce Biosciences, Inc.

Grade Last Price % Change Price Change
F 0.76 -6.06% -0.05
SPRB closed down 6.06 percent on Monday, March 18, 2024, on 3.35 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 13 hours ago
2x Volume Pace about 17 hours ago
1.5x Volume Pace about 17 hours ago
3x Volume Pace about 17 hours ago
10x Volume Pace about 17 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company develops tildacerfont, an non-steroidal therapy, which is in Phase IIb clinical trial for adult patients with classic congenital adrenal hyperplasia (CAH) and in Phase II clinical trial in children with classic CAH. It is also developing tildacerfont for females with polycystic ovary syndrome. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was founded in 2014 and is headquartered in Daly City, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Hyperplasia Endocrine Disorders Congenital Adrenal Hyperplasia Neurocrine Biosciences

Is SPRB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.95
52 Week Low 0.75
Average Volume 1,134,568
200-Day Moving Average 2.44
50-Day Moving Average 3.85
20-Day Moving Average 4.55
10-Day Moving Average 3.82
Average True Range 0.66
RSI (14) 21.26
ADX 33.87
+DI 12.96
-DI 50.09
Chandelier Exit (Long, 3 ATRs) 3.96
Chandelier Exit (Short, 3 ATRs) 2.74
Upper Bollinger Bands 7.72
Lower Bollinger Band 1.38
Percent B (%b) -0.1
BandWidth 139.41
MACD Line -0.56
MACD Signal Line 0.05
MACD Histogram -0.6051
Fundamentals Value
Market Cap 30.9 Million
Num Shares 40.7 Million
EPS -1.48
Price-to-Earnings (P/E) Ratio -0.51
Price-to-Sales 24.67
Price-to-Book 1.90
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.88
Resistance 3 (R3) 0.89 0.86 0.86
Resistance 2 (R2) 0.86 0.83 0.85 0.85
Resistance 1 (R1) 0.81 0.81 0.79 0.80 0.85
Pivot Point 0.78 0.78 0.77 0.77 0.78
Support 1 (S1) 0.73 0.75 0.71 0.72 0.67
Support 2 (S2) 0.70 0.73 0.69 0.67
Support 3 (S3) 0.65 0.70 0.66
Support 4 (S4) 0.64